THE INTERNATIONAL SOCIETY OF ENDOCRINOLO GY INC C/O THE CORPORATION TRUST INC (EIN 521095057) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1978

Principal Officer

HELEN VAN OERS

Phone

8473581170

Tax Period

2024-01-01 to 2024-12-31

THE INTERNATIONAL SOCIETY OF ENDOCRINOLO GY INC C/O THE CORPORATION TRUST INC, founded in 1978, is a small nonprofit in the Community Improvement sector that reported $386K in total revenue in fiscal year 2024. Revenue surged 66% from the prior year, signaling strong growth momentum. The organization ran a surplus of $67K, a strong 17% operating margin.

Mission

ISE IS THE GLOBAL NETWORK INTEGRATING ALL AREAS OF ENDOCRINOLOGY AND METABOLISM TO OPTIMIZE LIFE-LONG HEALTH FOR PEOPLE WITH ENDOCRINE DISORDERS. THE ORGANIZATION ACCOMPLISHES THIS BY FACILITATING COLLABORATION AND INTEGRATION ACROSS ENDOCRINE ORGANIZATIONS AND LIFE-LONG HEALTH FOR PEOPLE WITH ENDOCRINE DISORDERS

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $65,236

Program Service Revenue $295,201

Investment Income $25,297

Other Revenue $0

TOTAL REVENUE $385,734

Expense Breakdown

Grants Paid $13,595

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $115,230

Other Expenses $304,825

TOTAL EXPENSES $318,420

Year-over-Year Comparison

	2024	2023	Change
Revenue	$385,734	$231,851	+0.7%
Expenses	$318,420	$305,029	+0.0%
Net Income	$67,314	$-73,178	-1.9%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
SYED ABBAS RAZA	PRESIDENT	1.00	Officer Director	$0	$0	$0
ALVIN POWERS	SECRETARY	1.00	Officer Director	$0	$0	$0
HIROTAKA SHIBATA	TREASURER	1.00	Officer Director	$0	$0	$0
FATHEYA AL AWADI	DIRECTOR	1.00	Director	$0	$0	$0
VIVIEN LIM	DIRECTOR	1.00	Director	$0	$0	$0
AYESHA MOTALA	DIRECTOR	1.00	Director	$0	$0	$0
PEDRO NEL RUEDA PLATA	DIRECTOR	1.00	Director	$0	$0	$0
SUSAN MANDEL	SECRETARY-ELECT	1.00	Director	$0	$0	$0
HELENA TEEDE	PRESIDENT-ELECT	1.00	Director	$0	$0	$0
HIROSHI ARIMA	DIRECTOR	1.00	Director	$0	$0	$0
JEAN-PATRICE BAILLARGEON	DIRECTOR	1.00	Director	$0	$0	$0
IMPERIA BRAJKOVICH	DIRECTOR	1.00	Director	$0	$0	$0
NEIL HANLEY	DIRECTOR	1.00	Director	$0	$0	$0
SANJAY KALRA	DIRECTOR	1.00	Director	$0	$0	$0
BARBARA MCGOWAN	DIRECTOR	1.00	Director	$0	$0	$0
MARK SHERLOCK	DIRECTOR	1.00	Director	$0	$0	$0
HELEN VAN OERS	EXECUTIVE DIRECTOR	40.00	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$385,734	$318,420	$2,462,361	$67,314
2023	$231,851	$305,029	$2,273,052	$-73,178
2022	$163,412	$337,348	$2,150,683	$-173,936
2021	$403,141	$386,556	$2,728,768	$16,585
2020	$338,867	$331,906	$2,723,976	$6,961
2019	$335,313	$399,876	$2,570,445	$-64,563

THE INTERNATIONAL SOCIETY OF ENDOCRINOLO GY INC C/O THE CORPORATION TRUST INC